Defence Therapeutics Inc. (DTC) — Defensive Interval Ratio
Defence Therapeutics Inc. (DTC) has a Defensive Interval Ratio of 74 days as of December 2025. Defensive assets of €222.68K (cash €-, short-term investments €-, receivables €222.68K) cover 74 days of daily cash needs of €3.03K/day. See working capital to net assets of Defence Therapeutics Inc. to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defence Therapeutics Inc. Defensive Interval Ratio (2021–2024)
This chart shows how Defence Therapeutics Inc.'s Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2025, the ratio stands at 74 days, meaning defensive assets of €222.68K can fund 74 days of operations without new revenue. See how leveraged is Defence Therapeutics Inc.'s balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Defence Therapeutics Inc. (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Defence Therapeutics Inc. from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see DTC company net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 9 days | €96.52K | €11.11K/day | €- | €- | ▼ -239 days |
| 2023 | 248 days | €149.60K | €604.04/day | €- | €- | ▲ +239 days |
| 2022 | 9 days | €27.76K | €3.03K/day | €- | €- | ▼ -205 days |
| 2021 | 214 days | €71.62K | €334.95/day | €- | €- | — |